Shruti Gour

Title: Spotlight on Inventor Shruti Gour: Innovator in Pharmaceutical Chemistry

Introduction: Shruti Gour is a notable inventor based in Watertown, MA, recognized for her significant contributions to pharmaceutical chemistry. With a focus on developing innovative compounds, Shruti has made strides in the field, leading to the grant of her patent.

Latest Patents: Shruti holds a patent for her work on "Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate." This patent details processes for preparing crystalline forms of this compound and its tautomers, alongside pharmaceutical compositions that utilize these crystalline forms. Furthermore, the patent outlines methods for inhibiting cell division cycle 7 in mammals, as well as treatment methods for cancer mediated by this cycle.

Career Highlights: Shruti is affiliated with Takeda Pharmaceutical Company Limited, where she applies her expertise in developing therapeutic solutions. Her innovative work has not only led to advancements in cancer treatment but has also solidified her reputation within the pharmaceutical industry.

Collaborations: Throughout her career, Shruti has had the opportunity to collaborate with distinguished colleagues, including Kentaro Iwata and Masahiro Mizuno. These collaborations have enhanced her research initiatives and contributed to her success as an inventor in her field.

Conclusion: Shruti Gour exemplifies the spirit of innovation in the pharmaceutical sector. Her patented work on crystalline compounds not only showcases her inventive prowess but also highlights the significant impact that dedicated inventors can have on healthcare and treatment solutions. Her contributions continue to inspire and pave the way for future developments in pharmaceutical research.